The Organic Synthesis Core (Core C) will provide essential chemistry support for this research program through the synthesis and characterization of novel specialized pro-resolving mediators (SPM) and their sulfido-conjugates (SPM-SC). The Core will be responsible for the total synthesis of a panel of novel SPMs and related SPM probes, including: resolvins, maresins, sulfido-conjugates, and other related molecules that will be studied under this program. Core C will develop and utilize effective stereocontrolled synthetic pathways for the total synthesis of the targeted SPM in stereochemically pure form, and establish suitable methods for their detailed purification and structural verification using spectroscopic techniques. Core C will also prepare needed quantities (up to mg scale) of selected SPM, and will pursue the design and synthesis of selected derivatives that will enable their biological investigation. Core C will also prepare isotopically substituted SPM derivatives to serve as SPM probes for lipidomic profiling in collaboration with Core B and Project 1, 2, and 3, while other SPM probes will serve as precursors of radiolabelled derivatives for mechanistic studies. Finally, Core C will collaborate with Projects 1, 2 and 3 and Cores A-B on the proposed studies involving novel biological actions and cellular mechanisms of SPMs. Overall, these collaborative investigations will help elucidate key unexplored functions of SPMs, and will help validate their functional role(s) in the resolution of inflammation and tissue regeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM095467-09
Application #
9666933
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Winkler, Jeremy W; Libreros, Stephania; De La Rosa, Xavier et al. (2018) Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation. J Leukoc Biol :
Wu, Bian; Werlin, Evan C; Chen, Mian et al. (2018) Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg 68:188S-200S.e4
Motwani, Madhur P; Bennett, Frances; Norris, Paul C et al. (2018) Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation. Clin Pharmacol Ther 104:675-686
Norris, Paul C; Arnardottir, Hildur; Sanger, Julia M et al. (2018) Resolvin D3 multi-level proresolving actions are host protective during infection. Prostaglandins Leukot Essent Fatty Acids 138:81-89
Chiang, Nan; Riley, Ian R; Dalli, Jesmond et al. (2018) New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses. FASEB J 32:4043-4052
Krishnamoorthy, Nandini; Abdulnour, Raja-Elie E; Walker, Katherine H et al. (2018) Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 98:1335-1370
Chen, Gang; Zhang, Yu-Qiu; Qadri, Yawar J et al. (2018) Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 100:1292-1311
Tungen, J E; Aursnes, M; Ramon, S et al. (2018) Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents. Org Biomol Chem 16:6818-6823
Sulciner, Megan L; Serhan, Charles N; Gilligan, Molly M et al. (2018) Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med 215:115-140
Loynes, Catherine A; Lee, Jou A; Robertson, Anne L et al. (2018) PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. Sci Adv 4:eaar8320

Showing the most recent 10 out of 165 publications